M. Nerone

PCSK9 inhibitors for treating dyslipidemia in patients at different cardiovascular risk: a systematic review and a meta-analysis

R. Giugliano, F. Dentali, A. Grandi, 2017, Internal and Emergency Medicine.

Advancing antibody-drug conjugates in gynecological malignancies: myth or reality?

C. Sessa, I. Colombo, M. Nerone, 2022, Exploration of targeted anti-tumor therapy.

Whole-Body Composition Features by Computed Tomography in Ovarian Cancer: Pilot Data on Survival Correlations

M. Gasparri, A. Papadia, I. Colombo, 2023, Cancers.

Beyond PARP Inhibitors in Advanced Breast Cancer Patients with Germline BRCA1/2 Mutations: Focus on CDK4/6-Inhibitors and Data Review on Other Biological Therapies

A. Palazzo, F. Conforti, L. Rossi, 2023, Cancers.

Predictive variables of palbociclib dose reduction and its impact on survival outcomes: A retrospective bicentric study

L. Rossi, M. Nerone, I. Vallini, 2021, The breast journal.